Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 8;12:805613. doi: 10.3389/fonc.2022.805613

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zannoni, Bragantini, Castiglione, Fassan, Troncone, Inzani, Pesci, Santoro and Fraggetta

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Molecular landscape of endometrial carcinoma: the role of other immunohistochemical markers. (A) An endometrioid carcinoma G1 FIGO with nuclear beta-catenin expression in foci of morular metaplasia (LSAB, 20×). (B) An endometrioid carcinoma G2 FIGO with L1CAM over-expression (>10%) (LSAB, 4×). (C) A serous carcinoma with HER2 score 3+, according to the 2007 modified ASCO CAP scoring method (LSAB, 20×). (D) A clear cell carcinoma with HER2 score 2+, according to the 2007 modified ASCO CAP scoring method (LSAB, 20×).